Results 81 to 90 of about 876,919 (302)

Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health [PDF]

open access: yes, 2012
This report looks at how pharmaceutical and medical device companies can create shared value in global health by addressing unmet health needs in low- and middle-income countries.
Kyle Peterson   +3 more
core  

Value of MRI Outcomes for Preventive and Early‐Stage Trials in Spinocerebellar Ataxias 1 and 3

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the value of MRI outcomes as endpoints for preventive and early‐stage trials of two polyglutamine spinocerebellar ataxias (SCAs). Methods A cohort of 100 participants (23 SCA1, 63 SCA3, median Scale for the Assessment and Rating of Ataxia (SARA) score = 5, 42% preataxic, and 14 gene‐negative controls) was scanned at 3T up ...
Thiago J. R. Rezende   +26 more
wiley   +1 more source

Why licensing authorities need to consider the net value of new drugs in assigning review priorities: Addressing the tension between licensing and reimbursement [PDF]

open access: yes, 2008
Pharmaceutical regulators and healthcare reimbursement authorities operate in different intellectual paradigms and adopt very different decision rules. As a result, drugs that have been licensed are often not available to all patients who could benefit ...
Angell   +6 more
core   +1 more source

Structure–Function Decoupling of the Sensorimotor and Default Mode Networks in Black Americans With MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Multiple sclerosis (MS) exhibits racially disparate rates of disease progression. Black people with MS (B‐PwMS) experience a more severe disease course than non‐Hispanic White people with MS (NHW‐PwMS). Here we investigated structural and functional connectivity as well as structure–function decoupling in the ...
Emilio Cipriano   +11 more
wiley   +1 more source

HISTORY OF THE CHAIR OF PHARMACEUTICAL TECHNOLOGY

open access: yesСеченовский вестник, 2013
The article focuses on the history of the chair of pharmaceutical technology of the faculty of pharmacy of the I.M. Sechenov First MSMU since its inception as a structural unit of the Moscow pharmaceutical institute in 1934 to the present days.
I. I. Krasnyuk, S. A. Skatkov
doaj  

Application of membrane separation in biotechnology [PDF]

open access: yes, 2001
Membrane technology emerges as one of the most important separation methods, which have captured the attention of industries, related to biochemical, pharmaceutical, biomedical, and food industries. Due to the current intensive development and expansion,
Ismail, Ahmad Fauzi, Lai, Ping Yean
core  

Validity of a Wearable Digital Insole for Assessing Gait ON and OFF in Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Gait impairment is a distinctive symptom of Parkinson's disease that negatively impact mobility. We assessed the validity of wearable digital insoles against a validated reference gait analysis system for measuring select gait characteristics in patients with Parkinson's disease. Methods A comparative analysis between digital insoles
Deborah A. Hall   +16 more
wiley   +1 more source

Blockchain Applications in the Pharmaceutical Industry

open access: yesBlockchain in Healthcare Today
Background: In recent years, blockchain technology has made great strides in diverse industries but has fallen behind within the pharmaceutical industry.
Mark Gaynor   +4 more
doaj   +1 more source

The study of structural-mechanical characteristics of suppositories with clopidogrel

open access: yesAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2018
During last years clopidogrel keeps leading positions among medicines with platelet antiaggregation mechanism. The rectal dosage form with clopidogrel, namely suppository containing 0.075 g of active substance on hydrophilic base with addition of 2 ...
Ye. А. Redkina   +2 more
doaj   +1 more source

Health Biotechnology Innovation for Social Sustainability -A Perspective from China [PDF]

open access: yes, 2011
China is not only becoming a significant player in the production of high-tech products, but also an increasingly important contributor of ideas and influence in the global knowledge economy.
Chen, Yantai, Ely, Adrian
core   +1 more source

Home - About - Disclaimer - Privacy